Israeli biotechnology company Evogene announced plans to establish its U.S. headquarters at the Bio-Research & Development Growth (BRDG) Park in St. Louis, Missouri. The company’s expansion into Missouri includes a $1M capital investment and is expected to create 15 jobs in the next three years.